In a study using real-time PCR to assess ALK status in lung cancer, 33 ALK-positive and 28 ALK-negative patients, assessed by fluorescent in situ hybridization (FISH) break-apart, were enrolled. The gene discussed is ALK; the disease is lung carcinoma.